Rights and permissions
About this article
Cite this article
Additional indications have been approved in Japan for cisplatin [`Briplatin'; Bristol-Myers Squibb],. Inpharma Wkly. 1224, 22 (2000). https://doi.org/10.2165/00128413-200012240-00056
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012240-00056